Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.
Clinical trial NCT00131313 · UNKNOWN
Trial details
- NCT number
- NCT00131313
- Sponsor
- East Valley Hematology and Oncology Medical Group
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-01-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.